press_release_conclusion: Scientists from the School of Pharmacy at Queen’s University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.
abstract_conclusion: FKBPL and its peptide derivative AD-01 have potent antiangiogenic activity.